Prognostic factors in patients with advanced biliary tract cancer treated with first-line gemcitabine plus cisplatin: retrospective analysis of 740 patients

Purpose Biliary tract cancer (BTC) is a heterogeneous group of diseases comprising intrahepatic and extrahepatic cholangiocarcinoma and gallbladder cancer. Although gemcitabine plus cisplatin (GEMCIS) was established as the standard first-line chemotherapy based on the ABC-02 trial, more data are ne...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer chemotherapy and pharmacology 2017-07, Vol.80 (1), p.209-215
Hauptverfasser:	Kim, Bum Jun, Hyung, Jaewon, Yoo, Changhoon, Kim, Kyu-pyo, Park, Seong-Joon, Lee, Sang Soo, Park, Do Hyun, Song, Tae Jun, Seo, Dong Wan, Lee, Sung Koo, Kim, Myung-Hwan, Park, Jin-hong, Cho, Hyungwoo, Ryoo, Baek-Yeol, Chang, Heung-Moon
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biliary tract Cancer Cancer Research Chemotherapy Cholangiocarcinoma Cholangiocarcinoma - drug therapy Cholangiocarcinoma - pathology Cisplatin Cisplatin - administration & dosage Clinical trials Deoxycytidine - administration & dosage Deoxycytidine - analogs & derivatives Disease-Free Survival Female Follow-Up Studies Gallbladder Gallbladder cancer Gallbladder Neoplasms - drug therapy Gallbladder Neoplasms - pathology Gemcitabine Health care facilities Humans Male Medical research Medicine Medicine & Public Health Metastases Middle Aged Multivariate Analysis Oncology Original Article Patients Pharmacology/Toxicology Prognosis Republic of Korea Retrospective Studies Sex Factors Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!